Infectious Diseases – News and Features

The Fogarty International Center to award approximately $537,000 over three years to fund international research collaboration at five universities.

Malaysian Ministry of Health provides grant to develop blood-based diagnostic tests for liver cancer, Hepatitis B and nasopharyngeal cancer.

HEPLISAV met its primary endpoint in this Phase 3 trial and demonstrated the vaccine's potential to provide increased protection against hepatitis.

Company commercializes high throughput and portable nanotechnology based screening for Swine Flu and other pandemics.

Researchers discover a mechanism by which several viruses suppress aspects of the cell to stabilize their nucleic acids to promote an efficient infection.

Company’s GeneXpert® system capabilities enable new TB diagnostic tool.

German Bernhard Nocht Institute and Spanish Reference Laboratory detect infections with the H1N1 strain using QIAGEN’s artus influenza test.

Göttingen University study utilizes xCELLigence system from Roche Applied Science for testing of virus-mediated cytopathogenicity.

Partnership provides necessary support to develop Arisyn's portfolio of novel inhibitors for the treatment of infectious disease and cancer.

Durham University researchers are developing methods that show how proteins interact with cell membranes when a virus strikes.